Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease.
Emanuel Almeida Moreira de OliveiraKenia de Assis BoyAna Paula Pinho SantosCarla da Silva MachadoCibele Velloso-RodriguesPâmela Souza Almeida Silva GerheimLeonardo Meneghin MendonçaPublished in: Einstein (Sao Paulo, Brazil) (2019)
In the study population, patients with sickle cell disease treated with the standard dose of hydroxyurea treatment did not show evidence of DNA damage induction.